Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma
Abstract Genetic aberrations are present in the ATRX gene in older high-risk neuroblastoma (NB) patients with very poor clinical outcomes. Its loss-of-function (LoF) facilitates the alternative lengthening of telomeres (ALT) pathway in tumor cells and is strongly linked to replication stress (RS) an...
Saved in:
Main Authors: | Jesmin Akter, Yutaka Katai, Parvin Sultana, Hisanori Takenobu, Masayuki Haruta, Ryuichi P. Sugino, Kyosuke Mukae, Shunpei Satoh, Tomoko Wada, Miki Ohira, Kiyohiro Ando, Takehiko Kamijo |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a2daa5a4a53642579e6bb90d160a40c5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
by: Maged Zeineldin, et al.
Published: (2020) -
Disruption of ATRX-RNA interactions uncovers roles in ATRX localization and PRC2 function
by: Wenqing Ren, et al.
Published: (2020) -
Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
by: Alexandre de Nonneville, et al.
Published: (2021) -
ATRX is a regulator of therapy induced senescence in human cells
by: Marta Kovatcheva, et al.
Published: (2017) -
Formal reply to “Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX”
by: Lars Feuerbach
Published: (2021)